Westlake BioPartners Fund II, L.P.
Follow-ons only
Follow-ons only: no first sale reported; age from Form D filed Jul 2020 (approximate)
- Vintage
- Unknown
- Fund size
- $450M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- CA
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$4.5M to $7.5M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Scott Ryles, Chief Operating Officer of the General Partner
- Sean Harper, Managing Director of the General Partner
- Beth Seidenberg, Managing Director of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideWestlake BioPartners is a life science venture capital firm that puts people first and supports entrepreneurs from ideation and preclinical research through clinical and commercial impact.
Westlake BioPartners is a life science venture capital firm where every aspect of our approach is founded on the understanding that people are paramount to success.
https://westlakebio.com/about/
06 · Sources
Last verified: Oct 28, 2026